About Hyaluronic Acid
Hyaluronic acid is an ingredient which is naturally present in the human body. Hyaluronic acid (HA) is a glycosaminoglycan (GAG), which is an element that attaches to collagen and elastin to form cartilage. It is found in the eyes and joints as the highest concentrations in fluids. The hyaluronic acid is also used as medicine that is extracted from rooster combs or made by bacteria in the laboratory. Hyaluronic acid is also used in plastic surgery as a lip filler. The FDA has permitted the usage of hyaluronic acid in some eye surgeries like cataract removal, corneal transplantation and other eye injuries.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 7.7% |
The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing on production technologies, efficiency enhancement, and product life. This market has various growth opportunities that leading players capture via tracking the ongoing process enhancement and huge investment in market growth strategies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Hyaluronic Acid market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
F. Hoffmann-La Roche Ltd. (Switzerland), Seikagaku Corp. (Japan), Galderma S.A. (Switzerland), Sanofi (France), Anika Therapeutics, Inc. (United States), Salix Pharmaceuticals (United States), Zimmer Holdings, Inc. (United States), Allergan, Inc. (Ireland), Ferring Pharmaceuticals, Inc. (Switzerland), Smith & Nephew Plc (United Kingdom) and Bohus BioTech (Sweden) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Hyaluronic Acid market by Type (Single-Injection, Three-Injection Cycle and Five-Injection Cycle), Application (Anti-Aging Treatments, Nutritional Supplements, Medical Treatments and Others) and Region.
On the basis of geography, the market of Hyaluronic Acid has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Forms, the sub-segment i.e. Gel will boost the Hyaluronic Acid market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Online will boost the Hyaluronic Acid market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Increasing Implementation of Aesthetic Procedures
Market Growth Drivers:
Growing Popularity of Cosmetic Surgeries
Challenges:
Side-Effects after Undergoing Hyaluronic Acid Treatment
Restraints:
High Price of Hyaluronic Acid Products
Opportunities:
Rising Focus on Development of New Product
Market Leaders and their expansionary development strategies
On June 11, 2019- Smith & Nephew plc, the global medical technology business, today announces that it has agreed to acquire Atracsys Sàrl, the Switzerland-based provider of optical tracking technology used in computer-assisted surgery.
In March 2023, Givaudan Active Beauty launched PrimalHyal Hydra [+], a new cationic hyaluronic acid. This product is designed to outperform the hydration benefits of standard hyaluronic acid by at least a factor of two.
FDA encouraged sponsors of HA products to first obtain a classification and jurisdictional determination via a pre- or request for designation (RFD) prior to a premarket approval application (PMA) or a PMA supplement for a change in indications for use, formulation or route of administration. Sponsors may provide evidence in support of their products meeting the medical device definition in a pre-RFD or RFD.
Key Target Audience
Manufacturers of Hyaluronic Acid Products, Suppliers of Hyaluronic Acid Products, Wholesalers, Distributors and Retailers of Hyaluronic Acid Products, Healthcare Industry, Manufacturer of Cosmetic Products and Governmental Bodies
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.